ERYTECH Pharma S.A.

ERYP · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$38,789$33,699$44,446$73,173
Short-Term Investments$43$486$8$13
Receivables$2,533$4,230$4,334-$2,229
Inventory$1,268$0$0$358
Other Curr. Assets$1$0$0$10,268
Total Curr. Assets$42,634$40,048$49,632$81,583
Property Plant & Equip (Net)$2,976$25,829$29,090$35,639
Goodwill$0$0$0$0
Intangibles$5$15$589$603
Long-Term Investments$0$0$17$17
Tax Assets$0$0$0$701
Other NC Assets$196$876$1,074$3
Total NC Assets$3,177$26,720$30,770$36,963
Other Assets$0$0$0$0
Total Assets$45,811$66,768$80,402$118,546
Liabilities
Payables$1,562$2,485$4,706$5,074
Short-Term Debt$3,340$1,981$3,872$1,525
Tax Payable$0$3,716$4,149$3,628
Deferred Revenue$51$93$148$61
Other Curr. Liab.$6,725$11,730$16,472$9,593
Total Curr. Liab.$11,678$20,005$29,347$19,881
LT Debt$10,227$23,394$23,576$12,599
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$420$524$940$507
Total NC Liab.$10,647$23,918$24,516$13,106
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$22,325$43,923$53,863$32,987
Equity
Pref Stock$0$0$0$0
Common Stock$3,102$3,102$2,006$1,794
Retained Earnings-$228-$53,797-$73,300-$62,659
AOCI-$28,363-$24,078-$22,872-$135,264
Other Equity$48,975$97,618$120,705$281,688
Total Equity$23,486$22,845$26,539$85,559
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$45,811$66,768$80,402$118,546
Net Debt-$25,222-$8,324-$16,998-$59,049
ERYTECH Pharma S.A. (ERYP) Financial Statements & Key Stats | AlphaPilot